Company news
Pharmx Technologies Limited (ASX:PHX) news
Pharmx Technologies Limited news releases on 6ix. Latest, Aug 26, 2026: FY26 Results Presentation
Press releases & updates
FY26 Results Presentation
August 26, 2026
H1 FY26 Investor Presentation
February 24, 2026
Half Yearly Reports & Accounts
February 24, 2026
H1 FY26 Results Announcement
February 24, 2026
Pharmx and Sigma enter multi-year strategic alliance
February 22, 2026
Investor Presentation
August 19, 2025
FY25 Results
August 19, 2025
Appendix 4E & FY2025 Annual Report
August 19, 2025
Reinstatement to Quotation
July 11, 2025
Suspension from Quotation
July 11, 2025
Trading Halt
July 11, 2025
Pause in trading
July 11, 2025
NDSS Agreement Renewal and Supplier Growth Momentum
July 10, 2025
H1 FY25 Results Announcement
February 18, 2025
H1 FY25 Investor Presentation
February 18, 2025
Half Yearly Report and Accounts
February 18, 2025
Pharmx announces strategic partnership with Toniq
February 18, 2025
2024 Annual Report and Appendix 4E
August 26, 2024
FY24 Results
August 26, 2024
Update on Fred Appeals in Legal Proceedings
August 8, 2024
ATO confirms tax implications of return of share capital
July 17, 2024
Results for the HY ended 31 Dec 2023
February 22, 2024
Appendix 4D and HY Report for 31 Dec 2023
February 22, 2024
Response to ASX Price Query
February 12, 2024
Notice of Annual General Meeting/Proxy Form
October 19, 2023
Completion of sale of pharmacy software business
October 1, 2023
FY23 Results Investor Presentation
August 22, 2023
FY23 Results Announcement
August 22, 2023
FY23 Appendix 4E and Annual Report
August 22, 2023
Sale of Corum Pharmacy Software Business
July 21, 2023
Update on Legal Proceedings
April 21, 2023
Investor Presentation FY22
September 4, 2022
FY22 Results Release
August 29, 2022
Appendix 4E and Annual Report
August 29, 2022
PharmX Agreement - Supplementary Information
February 7, 2022
Symbion & ProPharma sign long term PharmX agreement
February 6, 2022
Resignation of Managing Director
January 31, 2022
Corum Agrees Sale of eCommerce Business Unit
December 19, 2021
Trading Update
December 8, 2021
Key Retail Pharmacy Groups signed on to drive PharmX growth
November 23, 2021
Corum Trading Update
October 28, 2021
Press Release and Investor Presentation
August 17, 2021
Quarterly Activity Report and Appendix 4C
July 29, 2021
Quarterly Activities Report and Appendix 4C
April 21, 2021
Arrotex Pharmaceuticals becomes strategic shareholder
November 5, 2020
Update on BAMM Agreement
October 30, 2020
Appendix 4C - quarterly
October 29, 2020
Completion of $5.6M Capital Raising
September 25, 2020
Corum Announces the Completion of PharmX Acquisition
September 4, 2020
Acquisition of Remaining 57% interest in PharmX
August 31, 2020